Razak Myat Htoo, Jittiwutikarn Jaroon, Suriyanon Vinai, Vongchak Tassanai, Srirak Namtip, Beyrer Chris, Kawichai Surinda, Tovanabutra Sodsai, Rungruengthanakit Kittipong, Sawanpanyalert Pathom, Celentano David D
Department of Epidemiology, Bloomberg School of Public Health, The Johns Hopkins University, 615 North Wolfe Street (E-6008), Baltimore, MD 21205, U.S.A.
J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):259-66. doi: 10.1097/00126334-200306010-00023.
The authors sought to determine sociodemographic and sexual and drug use risk factors for HIV infection among drug users in northern Thailand adjacent to the Golden Triangle. The authors enrolled patients admitted for inpatient drug detoxification at one treatment center in northern Thailand and studied HIV risks and prevalence using an interviewer-administered questionnaire and serum collection with HIV pretest and posttest counseling. Between February 1, 1999 and January 31, 2000, 1865 patients admitted for opiate and methamphetamine dependence completed study procedures. Overall HIV prevalence was 10.3%: 30.0% among 513 injection drug users (IDUs) and 2.8% among non-IDUs (OR = 14.8, 95% CI: 10.2, 21.6). HIV seroprevalence was 2.4% among exclusive methamphetamine users (98% of whom are non-IDUs) and 3.4% among opium smokers. Injection drug use was the dominant risk factor in multivariate models. Although Thailand is widely recognized as having a successful national response to the heterosexual HIV epidemic, seroprevalence in IDUs remains high. Despite a sharp increase of non-IDUs admitted to the drug treatment center, HIV infection and risks remained high among IDUs in northern Thailand. HIV prevention campaigns need to focus on IDUs and to implement harm reduction strategies to reduce transmission to IDUs and further contain the HIV epidemic in Thailand.
作者试图确定泰国北部与金三角相邻地区吸毒者中感染艾滋病毒的社会人口统计学、性及毒品使用风险因素。作者招募了泰国北部一家治疗中心收治的接受住院戒毒治疗的患者,通过访谈式问卷以及进行艾滋病毒检测前和检测后咨询的血清采集来研究艾滋病毒风险和流行情况。在1999年2月1日至2000年1月31日期间,1865名因阿片类药物和甲基苯丙胺依赖而入院的患者完成了研究程序。艾滋病毒总体流行率为10.3%:513名注射吸毒者中的流行率为30.0%,非注射吸毒者中的流行率为2.8%(比值比=14.8,95%置信区间:10.2, 21.6)。单纯使用甲基苯丙胺者(其中98%为非注射吸毒者)的艾滋病毒血清流行率为2.4%,吸烟者中的流行率为3.4%。在多变量模型中,注射吸毒是主要风险因素。尽管泰国被广泛认为在应对异性传播的艾滋病毒疫情方面取得了成功,但注射吸毒者中的血清流行率仍然很高。尽管戒毒治疗中心收治的非注射吸毒者数量急剧增加,但泰国北部注射吸毒者中的艾滋病毒感染率和风险仍然很高。艾滋病毒预防运动需要关注注射吸毒者,并实施减少伤害策略,以减少向注射吸毒者的传播,并进一步控制泰国的艾滋病毒疫情。